Title: Achim Schäffler: Innovator in Rheumatoid Arthritis Treatment
Introduction
Achim Schäffler is an inventor based in Beerfelden, Germany. He is currently associated with Horizon Pharma AG. Although he has not been granted any patents, he is actively involved in the development of innovative treatments for rheumatoid arthritis.
Latest Patent Applications
Achim's latest patent applications include a significant invention titled "Delayed-Release Glucocorticoid Treatment of Rheumatoid Arthritis by Improving Signs and Symptoms, Showing Major or Complete Clinical Response and by Preventing from Joint Damage." This invention focuses on treating patients suffering from rheumatoid arthritis by administering a delayed-release dosage form of a glucocorticoid. The goal is to achieve a reduction in signs and symptoms, a major or complete clinical response (remission), and to prevent structural damage to the joints.
Conclusion
Achim Schäffler is dedicated to advancing treatment options for rheumatoid arthritis, showcasing his commitment to innovation in the medical field. His work has the potential to significantly impact the lives of those affected by this condition.